$HON

Newly spun-off Honeywell Aerospace cuts 2026 forecast on supply-chain woes

Honeywell Aerospace, spun off from Honeywell and listed on Nasdaq in June, cut its 2026 organic sales growth forecast to 4% to 5% from 7% to 9% and projected adjusted EPS of $7.60 to $7.90, below the $8.86 average estimate, citing ongoing supply-chain constraints. Q2 sales rose to $4.52B, but core profit fell 7% and adjusted EPS fell to $1.87.

Original reporting
Published Aug 5, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HON
Bearish
high confidence
Mentioned
$HON
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$HONBearishHigh
01

Why it matters

The company’s 2026 outlook deterioration is explicitly linked to supply constraints that cap output and force a mix shift away from higher-margin aftermarket spares and services.

02

Market read

Fresh 2026 guidance and EPS range below consensus, tied to supply constraints and mix shift, is a direct catalyst for repricing the stock’s forward earnings power.

03

What to watch

The guidance change is driven by prioritization of commercial OEM deliveries and defense mix; traders should watch whether aftermarket backlog converts once constraints loosen.

Relevance 9/10Novelty 9/10Timing: reported Wednesday, after-hours guidance update for 2026

Background

Honeywell Aerospace spun off from Honeywell in June and is now reporting its first full set of post-separation operating dynamics, including separation costs and inventory obsolescence charges.

Company-level read

Ticker impact

$HONBearishHigh confidence
Context

Honeywell Aerospace cut its 2026 sales growth forecast and guided weaker adjusted EPS, citing persistent supply-chain constraints.

Expected impact

Likely bearish near-term as investors reprice 2026 growth and EPS expectations; follow-through depends on whether supply improves in 2H.

Evidence & confidence

The article provides specific forecast changes (organic sales growth 4% to 5% vs 7% to 9%, adjusted EPS $7.60 to $7.90 vs $8.86 consensus) tied directly to supply constraints and mix shift.

Market effects

Aerospace suppliers may face similar OEM prioritization and margin/mix headwinds if planemaker ramp-up continues to divert capacity.

No specific regional impact cited beyond global OEM and defense mix.

Supply-chain constraints affecting Boeing/Airbus ramp-up can propagate through global aerospace aftermarket timing and margins.

Counterpoint

If supply constraints ease faster than expected, the aftermarket demand strength could translate into a catch-up in later quarters, limiting long-term damage.

Key entities

  • Honeywell Aerospace

    Spun-off aerospace, engines, defense systems and aftermarket parts/services provider that lowered 2026 sales growth and issued weaker EPS guidance.

  • Josh Jepsen

    CFO quoted by Reuters saying demand is robust but it is a supply challenge.

  • Jim Currier

    CEO quoted saying secular end-market trends remain strong while supply constraints limited output growth.

  • Boeing

    Commercial OEM customer referenced as ramping production, influencing Honeywell Aerospace delivery prioritization.

  • Airbus

    Commercial OEM customer referenced as ramping production, influencing delivery prioritization.

Related articles

$HONMed

Honeywell Aerospace Dives More Than 23%

Wall Street slipped as oil rose and more earnings were reported. The S&P 500 fell 0.2% to 7,709.96, the Dow fell 0.9% to 53,885.10, and the Nasdaq fell 0.1% to 26,348.35. Honeywell Aerospace dropped 23.2% after results missed forecasts, with CFO Josh Jepsen citing supply chain constraints. Brent rose 3.8% to $82.49 amid Iran Strait of Hormuz deal talks.

$HONHighAI 9/10

Honeywell Aerospace Q2 2026 earnings miss, cuts full-year outlook

Honeywell Aerospace reported Q2 2026 sales of $4.5B, up 5% YoY, and adjusted EBIT of $995M, down 7%, missing Wall Street expectations cited by Barron’s. Adjusted EPS was $1.87. The company cut full-year organic sales growth to 4% to 5% and adjusted EBIT to $4.35B–$4.45B, citing supply chain constraints. Backlog rose to $18.2B.

$HONHighAI 9/10

Honeywell Aerospace Shares Plunge 20% as Newly Spun-Off Company Slashes 2026 Sales Outlook on Its First Report

Honeywell Aerospace shares fell about 20% to $163 after its first standalone quarterly report cut 2026 guidance. The company reported Q2 organic sales of $4.5B and adjusted EPS of $1.78, but lowered full-year organic sales growth to 4% to 5% and adjusted EPS to $7.60 to $7.90, citing supply chain constraints. It plans to add 50+ suppliers and raise supplier tooling spending.

$HONMedAI 8/10

Honeywell Aerospace Cuts 2026 Outlook As Supply Snags Bite

Honeywell Aerospace said supply constraints are hurting results and cut its 2026 outlook. The company cited a shift toward US defense and space work, higher spending on multi-sourcing and in-sourcing, and about $100 million in separation and inventory charges. In the latest quarter, adjusted EPS fell 32% while sales rose 5% to $4.52 billion, and it guided 2026 EPS of $7.60 to $7.90.

$HONMed

HON Stock Jumps After Its Quantum Computing Subsidiary Files For IPO

Honeywell International (HON) shares rose about 2% after-hours after its quantum computing subsidiary Quantinuum filed a U.S. IPO registration statement with the SEC. Honeywell holds about 54%. JPMorgan Chase and Morgan Stanley lead the offering. Quantinuum reported a net loss of $136.6 million on $5.2 million revenue for the quarter ended March 31.